Cu(II) Promotes Amyloid Pore Formation

Por Zhang, Hangyu, Rochet, Jean-Christophe, Stanciu, Lia A
Publicado no Biochem Biophys Res Commun (2015)

Rational Design of Charged Peptides that Self-Assemble into Robust Nanofibers as Immune-Functional Scaffolds

Por Zhang, Hangyu, Park, Jaehyung, Jiang, Yonghou, Woodrow, Kim A.
Publicado no Acta Biomater (2017)

In Vitro Study of α-Synuclein Protofibrils by Cryo-EM Suggests a Cu(2+)-Dependent Aggregation Pathway

Por Zhang, Hangyu, Griggs, Amy, Rochet, Jean-Christophe, Stanciu, Lia A.
Publicado em 2013

Core-shell nanoparticles for targeted and combination antiretroviral activity in gut-homing T cells

Por Cao, Shijie, Jiang, Yonghou, Zhang, Hangyu, Kondza, Nina, Woodrow, Kim A.
Publicado no Nanomedicine (2018)

Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study

Por Feng, Yiding, Jiang, Youhua, Zhao, Qiang, Liu, Jinshi, Zhang, Hangyu, Chen, Qixun
Publicado no BMC Surg (2020)

Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis

Por Ruan, Liping, Zhang, Hangyu, Luo, Hanlin, Liu, Jingping, Tang, Fushan, Shi, Ying-Kang, Zhao, Xiaojun
Publicado em 2009

Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis

Por Zhang, Hangyu, Guo, Jianhai, Gao, Song, Zhang, Pengjun, Chen, Hui, Wang, Xiaodong, Li, Xiaoting, Zhu, Xu
Publicado no Chin J Cancer Res (2017)

An Aqueous Media Based Approach for the Preparation of a Biosensor Platform Composed of Graphene Oxide and Pt-Black

Por Shi, Jin, Zhang, Hangyu, Snyder, Alexandra, Wang, Mei-xian, Xie, Jian, Porterfield, D. Marshall, Stanciu, Lia A.
Publicado em 2012

Optimization and comparison of CD4-targeting lipid–polymer hybrid nanoparticles using different binding ligands

Por Cao, Shijie, Jiang, Yonghou, Levy, Claire N., Hughes, Sean M., Zhang, Hangyu, Hladik, Florian, Woodrow, Kim A.
Publicado no J Biomed Mater Res A (2018)

Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients()

Por Zhang, Hangyu, Liu, Rujiao, Yan, Cong, Liu, Lulu, Tong, Zhou, Jiang, Weiqin, Yao, Ming, Fang, Weijia, Chen, Zhiyu
Publicado no Transl Oncol (2018)

A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin

Por Zheng, Yi, Tu, Xiaoxuan, Zhao, Peng, Jiang, Weiqin, Liu, Lulu, Tong, Zhou, Zhang, Hangyu, Yan, Cong, Fang, Weijia, Wang, Weilin
Publicado no Br J Cancer (2018)

A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells

Por Guo, Chao, Liu, Fangyuan, Qi, Jie, Ma, Jiahui, Lin, Shiqi, Zhang, Caiyun, Zhang, Qian, Zhang, Hangyu, Lu, Rong, Li, Xia
Publicado no Molecules (2018)

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

Por Zhang, Hangyu, Yuan, Liyun, Liu, Lulu, Yan, Cong, Cheng, Jinming, Fu, Qihan, Tong, Zhou, Jiang, Weiqin, Zheng, Yi, Zhao, Peng, Zhang, Guoqing, Fang, Weijia
Publicado no BMC Cancer (2020)

Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

Por Li, Bin, Yan, Cong, Zhu, Jiamin, Chen, Xiaobing, Fu, Qihan, Zhang, Hangyu, Tong, Zhou, Liu, Lulu, Zheng, Yi, Zhao, Peng, Jiang, Weiqin, Fang, Weijia
Publicado no Front Immunol (2020)

Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine

Por Tong, Zhou, Yan, Cong, Dong, Yu-An, Yao, Ming, Zhang, Hangyu, Liu, Lulu, Zheng, Yi, Zhao, Peng, Wang, Yimin, Fang, Weijia, Zhang, Feifei, Jiang, Weiqin
Publicado no BMC Med Genomics (2020)

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma

Por Dai, Xiaomeng, Guo, Yixuan, Hu, Yan, Bao, Xuanwen, Zhu, Xudong, Fu, Qihan, Zhang, Hangyu, Tong, Zhou, Liu, Lulu, Zheng, Yi, Zhao, Peng, Fang, Weijia
Publicado no Theranostics (2021)

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma

Por Zheng, Yi, Wang, Tingting, Tu, Xiaoxuan, Huang, Yun, Zhang, Hangyu, Tan, Di, Jiang, Weiqin, Cai, Shunfeng, Zhao, Peng, Song, Ruixue, Li, Peilu, Qin, Nan, Fang, Weijia
Publicado no J Immunother Cancer (2019)

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy

Por Bao, Xuanwen, Zhang, Hangyu, Wu, Wei, Cheng, Shaobing, Dai, Xiaomeng, Zhu, Xudong, Fu, Qihan, Tong, Zhou, Liu, Lulu, Zheng, Yi, Zhao, Peng, Fang, Weijia, Liu, Fanglong
Publicado no J Immunother Cancer (2020)

Carcinoma of Unknown Primary with EML4‐ALK Fusion Response to ALK Inhibitors

Por Zhao, Peng, Peng, Ling, Wu, Wei, Zheng, Yi, Jiang, Weiqin, Zhang, Hangyu, Tong, Zhou, Liu, Lulu, Ma, Ruobing, Wang, Liping, Yao, Ming, Wang, Kai, Fang, Weijia, Wu, Liming
Publicado no Oncologist (2019)